AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
WASHINGTON -- Aggressive breast tumors, known as "triple negatives," are significantly more common among black women--especially younger women--than in white women, reported Mary Jo B. Lund, Ph.D., at the annual meeting of the American Association for Cancer Research.
Tumors that test negative for three biomarkers--estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2)--are not only more aggressive than are other subtypes of breast cancer, but they can't be treated effectively with tamoxifen or trastuzumab, said Dr. Lund of Emory University in Atlanta.
Dr. Lund and her colleagues evaluated the potential racial differences in the incidence of triple-negative tumors in a group of 117 black women and 362 white women aged 20-54 years. The women had been diagnosed with breast cancer between 1990 and 1992 and were enrolled in a population-based, case-control breast cancer study in the Atlanta area.
The overall incidence of triple-negative tumors was 29.5%, but the tumors were significantly more common among black women, compared with ...
Source: HighBeam Research, Young black women at risk for aggressive breast tumors.(Gynecology)